10x Genomics Prix/Valeur
Quel est le Prix/Valeur de 10x Genomics?
Le Prix/Valeur de 10x Genomics, Inc. est 5.40
Quelle est la définition de Prix/Valeur?
Le ratio cours / valeur comptable représente le rapport entre la valeur des actions d'une entreprise et la valeur comptable par action.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Prix/Valeur des entreprises dans Health Care secteur sur NASDAQ par rapport à 10x Genomics
Que fait 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Entreprises avec prix/valeur similaire à 10x Genomics
- Cerner a Prix/Valeur de 5.39
- Plurilock Security a Prix/Valeur de 5.39
- Spirent Communications Plc a Prix/Valeur de 5.39
- Jindal Stainless (Hisar) a Prix/Valeur de 5.40
- Loop a Prix/Valeur de 5.40
- Volt Carbon Technologies Inc a Prix/Valeur de 5.40
- 10x Genomics a Prix/Valeur de 5.40
- EURO Ressources SA a Prix/Valeur de 5.40
- Adriatic Metals PLC a Prix/Valeur de 5.40
- Hoshi Resource Corp a Prix/Valeur de 5.40
- Varonis Systems Inc a Prix/Valeur de 5.41
- Antares Pharma Inc a Prix/Valeur de 5.41
- Altair Engineering Inc a Prix/Valeur de 5.41